Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative ColitisKoji Miyahara, Kazuhide Yamamoto, Keita Harada et al.|PLoS ONE|2013Cited by 51
Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenibKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Hepatology|2013Cited by 23